Gene · 9260
Papers4,249
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 4,249
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| LMP1 Induces p53 Protein Expression via the H19/miR-675-5p Axis. | Microbiol Spectr | 2022 | 35674441 | PubTator, text mining | PubMed |
| A High-Throughput Comet Assay Approach for Assessing Cellular DNA Damage. | J Vis Exp | 2022 | 35635461 | PubTator, text mining | PubMed |
| Data Mining Identifies CCN2 and THBS1 as Biomarker Candidates for Cardiac Hypertrophy. | Life (Basel) | 2022 | 35629393 | PubTator, text mining | PubMed |
| Extranodal Natural Killer/T-Cell Lymphomas: Current Approaches and Future Directions. | J Clin Med | 2022 | 35628826 | PubTator, text mining | PubMed |
| Leptin Silencing Attenuates Lipid Accumulation through Sterol Regulatory Element-Binding Protein 1 Inhibition in Nasopharyngeal Carcinoma. | Int J Mol Sci | 2022 | 35628510 | PubTator, text mining | PubMed |
| Therapeutic Application of Genome Editing Technologies in Viral Diseases. | Int J Mol Sci | 2022 | 35628210 | PubTator, text mining | PubMed |
| Current and Emerging Approaches to Study Microenvironmental Interactions and Drug Activity in Classical Hodgkin Lymphoma. | Cancers (Basel) | 2022 | 35626032 | PubTator, text mining | PubMed |
| Lymphoproliferation in Inborn Errors of Immunity: The Eye Does Not See What the Mind Does Not Know. | Front Immunol | 2022 | 35603189 | PubTator, text mining | PubMed |
| Recurrence 14 Years After Initial Treatment of Extranodal NK/T Cell Lymphoma, Nasal Type. | Cureus | 2022 | 35602784 | PubTator, text mining | PubMed |
| Bisphenol a exposure decreases learning ability through the suppression of mitochondrial oxidative phosphorylation in the hippocampus of male mice. | Food Chem Toxicol | 2022 | 35598803 | PubTator, text mining | PubMed |
| Extracellular Vesicles in the Progression and Therapeutic Resistance of Nasopharyngeal Carcinoma. | Cancers (Basel) | 2022 | 35565418 | PubTator, text mining | PubMed |
| Transcriptomic Profiling of Gene Expression Associated with Granulosa Cell Tumor Development in a Mouse Model. | Cancers (Basel) | 2022 | 35565312 | PubTator, text mining | PubMed |
| The Role of Extracellular Vesicles in Metabolic Reprogramming of the Tumor Microenvironment. | Cells | 2022 | 35563739 | PubTator, text mining | PubMed |
| Cullin 3 Exon 9 Deletion in Familial Hyperkalemic Hypertension Impairs Cullin3-Ring-E3 Ligase (CRL3) Dynamic Regulation and Cycling. | Int J Mol Sci | 2022 | 35563538 | PubTator, text mining | PubMed |
| Identification of Potential Muscle Biomarkers in McArdle Disease: Insights from Muscle Proteome Analysis. | Int J Mol Sci | 2022 | 35563042 | PubTator, text mining | PubMed |
| Immune Checkpoint Inhibitors in Peripheral T-Cell Lymphoma. | Front Pharmacol | 2022 | 35559250 | PubTator, text mining | PubMed |
| Current status and advances of immunotherapy in nasopharyngeal carcinoma. | Ther Adv Med Oncol | 2022 | 35547095 | PubTator, text mining | PubMed |
| Pancreatic INS-1 β-Cell Response to Thapsigargin and Rotenone: A Comparative Proteomics Analysis Uncovers Key Pathways of β-Cell Dysfunction. | Chem Res Toxicol | 2022 | 35544339 | PubTator, text mining | PubMed |
| Effective treatment of advanced Hodgkin lymphoma with a modified BEACOPP regimen for a patient with demyelinating hereditary motor and sensory neuropathy type 1 (HMSN1). | Clin Case Rep | 2022 | 35540715 | PubTator, text mining | PubMed |
| Clinical presentation, outcome, and prognostic markers in patients with intravascular large B-cell lymphoma, a lymphoma study association (LYSA) retrospective study. | Cancer Med | 2022 | 35538643 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9260/papers?page=31